Member Info for technick

What a great RNS

Agree a lot of potential if (when) the various programs come in. Before that though it is not a done deal and its a question of holding your nerve. If the projects come in as they look to be signing up then we will be rewarded. Other investors will want to wait until the comes in to reduce their risk and in doing so accept a smaller return on investment.... Of course if there are unexpected delays then they have risked less. Things looking good here, certainly 'leaked' indications of 140mm+ gives an uplift of 2.2p per share for WN on its own. Wressle seems to be positive in terms of being able to produce income in 2020 too which would be further uplift, and then Biscapthorpe side-drill could show the hydrocarbons found there could have commercial potential and provide more uplift. Of course these all of the potential for delays but it does seem to be a question of when not if... Exciting times here, I bought almost year ago and happy to still hold because I've been happy with DB and his strategy, pragmatism and communication. Exciting times ahead that's for sure!

predictions so far range from 100-179 MMbbl. IF these predictions are close then it will be transformational for the business and according to recent tables publicised would equate up to an upside to the current share price of 2.2p. Time will tell and for balance of course if the oil can't be got at or the oil isn't there then this upside is meaningless, but it's a bit like guessing the baby's weight, we know its due, its just a case of how big will it really be?

Mine is 100-120 MMbbl

Just for fun, does anyone want to have an educated guess on WN MMbbl?

The share that keep on giving

in the blue again

Agree, probably some fraction above the brokers estimate of around 60p, perhaps not unrealistic, certainly when clinical sales start coming in.

great news...

I think the technology would be attractive to other diagnostics businesses, it represents significant investment and intellectual property which is getting more and more validation as it is used. I can't find any other POC PCR machine in the market, that makes it attractive for one of the larger businesses to acquire it, particularly at the low share price. That said it's bargain price might also make it less attractive because of the costs involved in the acquisition process... My money is on a trade sale in the next 12 months as sales start to be reported in the accounts. The AIHL test could be worth up to £3m in sales per annum in the UK then the market cap of £6m seems highly attractive to one of the big players in this market....

It shows a strong solid line of new product development which will further secure the business as a supplier of AI medical imaging diagnostics and build the potential to drive sales. Great news. Their FDA approval further strengthens their position.

This Company is rapidly becoming a global leader in AI medical imaging diagnostics, fantastic news and shows the potential to evolve their AI algorithms horizontally into new diagnostic areas. Smart.

I wonder what it is going to take for the MM to close the spread and allow trading, over 30% is not going to entice activity either way, we seemed to be locked in some kind of limbo. I can’t invest further with the lack of fluidity, I guess not many PIs so we wait for some event such as a trade sale perhaps?

A more commercially focused annual report this year with two assays now in market. I agree with your assessment for AIHL, the cost benefit in testing compared with the ongoing costs for hearing loss is a massive benefit. This test has a lot of potential both here in the UK and also in other countries. Once sales start being accounted the share price should rise to reflect the sales. Going to be an interesting 12 month period coming up.

But it’s not a Friday ;)

anyone else think the abrupt cessation of trading at 2pm was a little odd? nothing traded since 2pm today, not typical of this share I'm sure?

Ah ok that makes sense. I guess you never know. It's all success based and success is never guaranteed. I invested as its in two of my areas of interest, AI and medtech.... Time will tell if the company have that killer app or not, seems well priced and a sensible entry point to me, my opinion only

Not really sure what message the poster was trying to convey?

was there really an abrupt halt to shares being traded at 2pm? Very odd to have no trades this afternoon?

StoneChecker predicts the ease of SWL fragmentation and number of pulses required as far as I understand, this method uses ultrasound SWL fragmentation but in a portable unit so it does look to be compatible. It may require some 'tuning' to account fro differences in intensity and duration though I suspect these are standardised?